A Genome-wide Association Scan on Estrogen Receptor-negative Breast Cancer

IntroductionBreast cancer is a heterogeneous disease and may be characterized on the basis of whether estrogen receptors (ER) are expressed in the tumour cells. ER status of breast cancer is important clinically, and is used both as a prognostic indicator and treatment predictor. In this study, we focused on identifying genetic markers associated with ER-negative breast cancer risk.MethodsWe conducted a genome-wide association analysis of 285,984 single nucleotide polymorphisms (SNPs) genotyped in 617 ER-negative breast cancer cases and 4,583 controls. We also conducted a genome-wide pathway analysis on the discovery dataset using permutation-based tests on pre-defined pathways. The extent of shared polygenic variation between ER-negative and ER-positive breast cancers was assessed by relating risk scores, derived using ER-positive breast cancer samples, to disease state in independent, ER-negative breast cancer cases.ResultsAssociation with ER-negative breast cancer was not validated for any of the five most strongly associated SNPs followed up in independent studies (1,011 ER-negative breast cancer cases, 7,604 controls). However, an excess of small P-values for SNPs with known regulatory functions in cancer-related pathways was found (global P = 0.052). We found no evidence to suggest that ER-negative breast cancer shares a polygenic basis to disease with ER-positive breast cancer.ConclusionsER-negative breast cancer is a distinct breast cancer subtype that merits independent analyses. Given the clinical importance of this phenotype and the likelihood that genetic effect sizes are small, greater sample sizes and further studies are required to understand the etiology of ER-negative breast cancers.

[1]  L. Liang,et al.  A genome-wide association study of global gene expression , 2007, Nature Genetics.

[2]  Marylyn D Ritchie,et al.  Using prior knowledge and genome-wide association to identify pathways involved in multiple sclerosis , 2009, Genome Medicine.

[3]  A. Uitterlinden,et al.  Tissue Effect on Genetic Control of Transcript Isoform Variation , 2009, PLoS genetics.

[4]  Christian Gieger,et al.  Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.

[5]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[6]  Yuan Chen,et al.  A new permutation strategy of pathway-based approach for genome-wide association study , 2009, BMC Bioinformatics.

[7]  Murim Choi,et al.  Susceptibility loci for intracranial aneurysm in European and Japanese populations , 2008, Nature Genetics.

[8]  O. A. Cabello,et al.  Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways , 2005, Nature Genetics.

[9]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[10]  C. Wijmenga,et al.  Using genome‐wide pathway analysis to unravel the etiology of complex diseases , 2009, Genetic epidemiology.

[11]  Allan Peter Davis,et al.  Genetic and environmental pathways to complex diseases , 2009, BMC Systems Biology.

[12]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[13]  P. Matthews,et al.  Pathway and network-based analysis of genome-wide association studies in multiple sclerosis , 2009, Human molecular genetics.

[14]  Michael R. Kosorok,et al.  Detection of gene pathways with predictive power for breast cancer prognosis , 2010, BMC Bioinformatics.

[15]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[16]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[17]  Anbupalam Thalamuthu,et al.  A combined analysis of genome-wide association studies in breast cancer , 2011, Breast Cancer Research and Treatment.

[18]  Päivi Rosenström,et al.  NordicDB: a Nordic pool and portal for genome-wide control data , 2010, European Journal of Human Genetics.

[19]  Elizabeth A. Heron,et al.  The SNP ratio test: pathway analysis of genome-wide association datasets , 2009, Bioinform..

[20]  H. Nevanlinna,et al.  Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? , 2000, European journal of cancer.

[21]  Kai Wang,et al.  Pathway-based approaches for analysis of genomewide association studies. , 2007, American journal of human genetics.

[22]  I. Pedroso.  Gaining a pathway insight into genetic association data. , 2010, Methods in molecular biology.

[23]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[24]  D. Yee,et al.  Insulin-like growth factors and breast cancer. , 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[26]  Jaana M. Hartikainen,et al.  A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.

[27]  C. Hoggart,et al.  Genome-wide association analysis of metabolic traits in a birth cohort from a founder population , 2008, Nature Genetics.

[28]  Mitul Shah,et al.  Familial relative risks for breast cancer by pathological subtype: a population-based cohort study , 2010, Breast Cancer Research.

[29]  Peter Kraft,et al.  Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. , 2010, Cancer research.

[30]  W. Willett,et al.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) , 2009, Nature Genetics.

[31]  G. Dontu,et al.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.

[32]  Nicholas J Wareham,et al.  Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer. , 2005, Human molecular genetics.

[33]  Momiao Xiong,et al.  Gene and pathway-based second-wave analysis of genome-wide association studies , 2010, European Journal of Human Genetics.

[34]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[35]  S. Chanock,et al.  Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status , 2008, Clinical Cancer Research.

[36]  Wj Gauderman,et al.  QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies , 2006 .

[37]  P. Hall,et al.  Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women , 2006, Cancer Epidemiology Biomarkers & Prevention.

[38]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[40]  Päivi Heikkilä,et al.  Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients , 2005, International journal of cancer.

[41]  Anbupalam Thalamuthu,et al.  TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. , 2007, The New England journal of medicine.

[42]  Päivi Heikkilä,et al.  NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer , 2008, Nature Genetics.

[43]  D. Yee,et al.  Insulin-like growth factor-I and breast cancer therapy. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  D. Thomas,et al.  Gene–environment-wide association studies: emerging approaches , 2010, Nature Reviews Genetics.

[45]  K Holli,et al.  Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. , 2000, Journal of the National Cancer Institute.

[46]  H. Moses,et al.  Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. , 2007, The Journal of clinical investigation.

[47]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[48]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[49]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[50]  J. Haines,et al.  Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.

[51]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[52]  R. Kreienberg,et al.  Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. , 2008, Gynecologic oncology.

[53]  Adam L. Meadows,et al.  Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis. , 2006, Metabolic engineering.

[54]  D. Yee,et al.  Insulin-like growth factors and breast cancer therapy. , 2007, Advances in experimental medicine and biology.

[55]  Paul D P Pharoah,et al.  The admixture maximum likelihood test: a novel experiment‐wise test of association between disease and multiple SNPs , 2006, Genetic epidemiology.

[56]  P. Deloukas,et al.  Common Regulatory Variation Impacts Gene Expression in a Cell Type–Dependent Manner , 2009, Science.

[57]  M. Smid,et al.  Functional identification of genes causing estrogen independence of human breast cancer cells , 2009, Breast Cancer Research and Treatment.

[58]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.